G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer

NCT00541125 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: bevacizumab
BIOLOGICAL: filgrastim
DRUG: fluorouracil
DRUG: irinotecan hydrochloride
DRUG: leucovorin calcium

Sponsor

Federation Francophone de Cancerologie Digestive